BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. The company focuses on two business segments, Brain Cooling and Oncology.
BrainCool develops products for medical cooling treatments for a wide range of diseases, including stroke, sudden cardiac arrest, oral mucositis, migraine, and (mild) traumatic brain injury within sports medicine. BrainCool dramatically advances standard of care in these markets. The lead products, BrainCool™ System and RhinoChill™ System, facilitate rapid medical cooling treatment in an emergency setting for stroke and sudden cardiac arrest patients through selective brain cooling functions.
BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Spotlight Stockmarket.